NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
651 Sunderby |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 47 | 0.3% | 4 | 0.0% | . | . | 3 | 0.0% | . | . | . | . | 1 | 0.0% | 13797 | 99.6% | 13852 | 100.0% |
ASCUS | 36 | 6.6% | 68 | 12.4% | . | . | 52 | 9.5% | . | . | . | . | 4 | 0.7% | 388 | 70.8% | 548 | 100.0% |
CIN1 | 26 | 12.1% | 55 | 25.6% | . | . | 57 | 26.5% | 2 | 0.9% | . | . | 3 | 1.4% | 72 | 33.5% | 215 | 100.0% |
Atypical glandular cells/AGC | 3 | 33.3% | 1 | 11.1% | . | . | 2 | 22.2% | 1 | 11.1% | . | . | 1 | 11.1% | 1 | 11.1% | 9 | 100.0% |
Unclear atypia | 3 | 20.0% | . | . | . | . | 9 | 60.0% | . | . | 1 | 6.7% | 1 | 6.7% | 1 | 6.7% | 15 | 100.0% |
ASC-H | 3 | 8.1% | 2 | 5.4% | . | . | 26 | 70.3% | 1 | 2.7% | 2 | 5.4% | 2 | 5.4% | 1 | 2.7% | 37 | 100.0% |
CIN2 | . | . | . | . | . | . | 2 | 100.0% | . | . | . | . | . | . | . | . | 2 | 100.0% |
CIN3 | 1 | 1.9% | 1 | 1.9% | . | . | 44 | 81.5% | 2 | 3.7% | 5 | 9.3% | . | . | 1 | 1.9% | 54 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | 1 | 100.0% |
Squamous cell cancer | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | . | . | . | . | 1 | 100.0% |
Total | 119 | 0.8% | 131 | 0.9% | . | . | 196 | 1.3% | 6 | 0.0% | 9 | 0.1% | 12 | 0.1% | 14261 | 96.8% | 14734 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81401, M81403 |